Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.56% is 100% above its 5-year average of -729.50%, near the high end of its 5-year range (-4686.64%–16.64%).
74.39% below its 12-month average of 2.19%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 9.16%.
NET PROFIT MARGIN
0.56%
NET PROFIT MARGIN AVG TTM
2.19%
NET PROFIT MARGIN AVG 3Y
-52.04%
NET PROFIT MARGIN AVG 5Y
-729.50%
NET PROFIT MARGIN AVG 10Y
-1026.99%
NET PROFIT MARGIN AVG 15Y
-1005.92%
NET PROFIT MARGIN AVG 20Y
-737.68%
CURRENT VS TTM AVG
-74.39%
CURRENT VS 3Y AVG
+101.08%
CURRENT VS 5Y AVG
+100.08%
CURRENT VS 10Y AVG
+100.05%
CURRENT VS 15Y AVG
+100.06%
CURRENT VS 20Y AVG
+100.08%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 735 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Delcath Systems, Inc.
Market Cap
$539.58M
Net Profit Margin
0.56%
TTM Avg
2.19%
3Y Avg
-52.04%
5Y Avg
-729.50%
Market Cap
$540.01M
Net Profit Margin
-41.34%
TTM Avg
-365.72%
3Y Avg
-7572.59%
5Y Avg
-5048.40%
Market Cap
$534.64M
Net Profit Margin
-10599.76%
TTM Avg
-44116.54%
3Y Avg
-22058.27%
5Y Avg
-14705.51%
Market Cap
$528.79M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$549.33M
Net Profit Margin
-921.50%
TTM Avg
-767.53%
3Y Avg
-527.58%
5Y Avg
-706.89%
Market Cap
$546.52M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$552.54M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$522.68M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$520.39M
Net Profit Margin
-1371.51%
TTM Avg
-709.80%
3Y Avg
-108166.39%
5Y Avg
-73106.10%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Delcath Systems, Inc. (DCTH) | $539.58M | 0.56% | 2.19% | -52.04% | -729.50% |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $540.01M | -41.34% | -365.72% | -7572.59% | -5048.40% |
| ProKidney Corp. (PROK)vs › | $534.64M | -10599.76% | -44116.54% | -22058.27% | -14705.51% |
| Immix Biopharma, Inc. (IMMX)vs › | $528.79M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $549.33M | -921.50% | -767.53% | -527.58% | -706.89% |
| Nuvectis Pharma, Inc. (NVCT)vs › | $546.52M | 0.00% | 0.00% | 0.00% | 0.00% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $552.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| Monopar Therapeutics Inc. (MNPR)vs › | $522.68M | 0.00% | 0.00% | 0.00% | 0.00% |
| Crescent Biopharma, Inc. (CBIO)vs › | $520.39M | -1371.51% | -709.80% | -108166.39% | -73106.10% |
| Altimmune, Inc. (ALT)vs › | $519.25M | -296000.00% | -345077.99% | -146585.06% | -98190.17% |
Operating Margin
-1.9%
Net Profit Margin
0.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 9.16% |
| 2026-03-31 | -4.28% |
| 2025-12-31 | -9.15% |
| 2025-09-30 | 4.04% |
| 2025-06-30 | 11.16% |
| 2025-03-31 | 5.40% |
| 2024-12-31 | -22.50% |
| 2024-09-30 | 16.64% |
| 2024-06-30 | -176.94% |
| 2024-03-31 | -353.97% |
| 2023-12-31 | -2066.05% |
| 2023-09-30 | -4686.64% |
| 2023-06-30 | -1454.95% |
| 2023-03-31 | -1507.54% |
| 2022-12-31 | -1587.32% |
| 2022-09-30 | -979.80% |
| 2022-06-30 | -1274.65% |
| 2022-03-31 | -2380.95% |
| 2021-12-31 | -253.65% |
| 2021-09-30 | -1364.94% |
| 2021-06-30 | -1199.63% |
| 2021-03-31 | -1738.92% |
| 2020-12-31 | -1386.39% |
| 2020-09-30 | -1071.03% |
| 2020-06-30 | -1127.97% |
| 2020-03-31 | -2673.81% |
| 2019-12-31 | 2416.25% |
| 2019-09-30 | -1978.68% |
| 2019-06-30 | -1446.36% |
| 2019-03-31 | -2923.33% |
| 2018-12-31 | -1062.46% |
| 2018-09-30 | -1077.67% |
| 2018-06-30 | -775.99% |
| 2018-03-31 | 1023.79% |
| 2017-12-31 | -2733.52% |
| 2017-09-30 | -1841.52% |
| 2017-06-30 | -332.71% |
| 2017-03-31 | -1525.17% |
| 2016-12-31 | -1255.33% |
| 2016-09-30 | -231.03% |
| 2016-06-30 | -1304.70% |
| 2016-03-31 | -490.00% |
| 2015-12-31 | -1160.14% |
| 2015-09-30 | -607.02% |
| 2015-06-30 | -793.78% |
| 2015-03-31 | -785.59% |
| 2014-12-31 | -1012.03% |
| 2014-09-30 | -2100.46% |
| 2014-06-30 | -1832.67% |
| 2014-03-31 | -1702.58% |
| 2013-12-31 | -1417.46% |
| 2013-09-30 | -10008.33% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | -3371.39% |
| 2012-12-31 | -5329.00% |
| 2012-09-30 | -30289.74% |
| 2012-06-30 | -13690.57% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-10-21 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
